MONOMETHYL FUMARATE (is an active metabolite) | MONOMETHYL FUMARATE | ATC N07XX09 ATC L04AX07
NERVOUS SYSTEM TREATMENT OF TREATMENT OF PATIENTS WITH RELAPSING FORMS OF MULTIPLE SCLEROSIS ACTIVATES THE NUCLEAR FACTOR (ERYTHROID-DERIVED 2)-LIKE 2 (NRF2) PATHWAY NICOTINIC ACID RECEPTOR AGONIST | ORAL | Cmax 12.9 MICROMOLAR Tmax 2.25 HOUR VD 63 LITER PPB 36 PERCENT Cl 43.6 LITER / HOUR (EQN) HT 1 HOUR | NICOTINIC ACID RECEPTOR (NIACR) | KELCH-LIKE ECH-ASSOCIATED PROTEIN 1 INHIBITOR CHEMBL2069156 KELCH-LIKE ECH-ASSOCIATED PROTEIN 1 Q14145 KELCH-LIKE ECH-ASSOCIATED PROTEIN 1 HOMO SAPIENS UNCLASSIFIED | EMA ANSM (in French) Inxight Drugs Dailymed Drugs.com SIDER side effects Chemical Probes Portal ChEMBL BindingDB DrugBank |